-
EP1341526
European procedure
Extract from the Register of European Patents
EP About this file: EP1341526
| EP1341526 - PHARMACEUTICAL COMPOSITIONS FOR THE ORAL DELIVERY OF CALCITONIN [Right-click to bookmark this link] | |||
| Former [2003/37] | PHARMACEUTICAL COMPOSITIONS FOR THE ORAL DELIVERY OF PHARMACOLOGICALLY ACTIVE AGENTS | ||
| [2010/36] | Status | No opposition filed within time limit Status updated on 27.04.2012 Database last updated on 21.05.2024 | Most recent event Tooltip | 13.07.2012 | Lapse of the patent in a contracting state | published on 15.08.2012 [2012/33] | Applicant(s) | For:BE
CH
CY
DE
DK
ES
FI
FR
GB
GR
IE
IT
LI
LU
MC
NL
PT
SE
TR
Novartis AG Lichtstrasse 35 4056 Basel / CH | For:AT
Novartis Pharma GmbH Brunner Strasse 59 1230 Wien / AT | [2011/25] |
| Former [2003/37] | For:BE
CH
CY
DE
DK
ES
FI
FR
GB
GR
IE
IT
LU
MC
NL
PT
SE
TR
LI
Novartis AG Lichtstrasse 35 4056 Basel / CH | ||
| For:AT
Novartis Pharma GmbH Brunner Strasse 59 1230 Wien / AT | Inventor(s) | 01 /
AULT, Joseph, M. Four Wards Road Blairstown, NJ 07825 / US | 02 /
AZRIA, Moise Bundesplatz 6 CH-4054 Basel / CH | 03 /
BATEMAN, Simon, David 4 Farrington Lane Randolph, NJ 07869 / US | 04 /
SIKORA, Joseph 16 Toby Drive Succasunna, NJ 07876 / US | 05 /
SPARTA, Gregory 66 Claire Drive Bridgewater, NJ 08807 / US | 06 /
YANG, Rebecca, Fai-Ying 7 Hawser Way Randolph, NJ 07869 / US | 07 /
XIAO, Jie 18 Parkview Road Randolph, NJ 07869 / US | [2003/37] | Representative(s) | de Weerd, Petrus G.W., et al Novartis International AG Corporate Intellectual Property 4002 Basel / CH | [N/P] |
| Former [2005/12] | de Weerd, Petrus G.W., et al Novartis International AG Corporate Intellectual Property 4002 Basel / CH | ||
| Former [2003/37] | Grubb, Philip William Novartis AG, Corporate Intellectual Property, Lichtstrasse 35 4002 Basel / CH | Application number, filing date | 01985368.8 | 05.12.2001 | [2003/37] | WO2001EP14294 | Priority number, date | US20000251729P | 06.12.2000 Original published format: US 251729 P | [2003/37] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO0245754 | Date: | 13.06.2002 | Language: | EN | [2002/24] | Type: | A2 Application without search report | No.: | EP1341526 | Date: | 10.09.2003 | Language: | EN | The application published by WIPO in one of the EPO official languages on 13.06.2002 takes the place of the publication of the European patent application. | [2003/37] | Type: | B1 Patent specification | No.: | EP1341526 | Date: | 22.06.2011 | Language: | EN | [2011/25] | Search report(s) | International search report - published on: | EP | 03.01.2003 | Classification | IPC: | A61K9/20, A61K38/23 | [2010/36] | CPC: |
A61K9/2027 (EP,US);
A61K9/20 (KR);
A61K47/183 (EP,US);
A61K9/2013 (EP,US);
A61P19/08 (EP);
A61P19/10 (EP);
|
| Former IPC [2003/37] | A61K9/20 | Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2003/37] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | RO | 07.07.2003 | SI | 07.07.2003 | Title | German: | PHARMAZEUTISCHE ZUSAMMENSETZUNGEN ZUR ORALEN VERABREICHUNG VON CALCITONIN | [2010/36] | English: | PHARMACEUTICAL COMPOSITIONS FOR THE ORAL DELIVERY OF CALCITONIN | [2010/36] | French: | COMPOSITIONS PHARMACEUTIQUES UTILISEES DANS L'ADMINISTRATION ORALE DE LA CALCITONINE | [2010/36] |
| Former [2003/37] | PHARMAZEUTISCHE ZUSAMMENSETZUNGEN ZUR ORALE VERABREICHUNG VON PHARMAZEUTISCHE WIRKSTOFFE | ||
| Former [2003/37] | PHARMACEUTICAL COMPOSITIONS FOR THE ORAL DELIVERY OF PHARMACOLOGICALLY ACTIVE AGENTS | ||
| Former [2003/37] | COMPOSITIONS PHARMACEUTIQUES UTILISEES DANS L'ADMINISTRATION ORALE DE PRINCIPES ACTIFS SUR LE PLAN PHARMACOLOGIQUE | Entry into regional phase | 07.07.2003 | National basic fee paid | 07.07.2003 | Designation fee(s) paid | 07.07.2003 | Examination fee paid | Examination procedure | 19.06.2002 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 07.07.2003 | Examination requested [2003/37] | 03.08.2007 | Despatch of a communication from the examining division (Time limit: M06) | 05.02.2008 | Reply to a communication from the examining division | 19.06.2009 | Despatch of a communication from the examining division (Time limit: M06) | 23.12.2009 | Reply to a communication from the examining division | 14.09.2010 | Communication of intention to grant the patent | 17.01.2011 | Fee for grant paid | 17.01.2011 | Fee for publishing/printing paid | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 03.08.2007 | Opposition(s) | 23.03.2012 | No opposition filed within time limit [2012/22] | Fees paid | Renewal fee | 02.01.2004 | Renewal fee patent year 03 | 03.01.2005 | Renewal fee patent year 04 | 02.01.2006 | Renewal fee patent year 05 | 02.01.2007 | Renewal fee patent year 06 | 12.12.2007 | Renewal fee patent year 07 | 31.03.2008 | Renewal fee patent year 08 | 11.12.2009 | Renewal fee patent year 09 | 15.12.2010 | Renewal fee patent year 10 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | MC | 31.12.2011 | [2012/33] | Cited in | International search | [XY]US5002771 (PURKAYSTHA ABDUR R [US], et al) [X] 1-4,12 * column 12, lines 34-41; claims 1-7 * [Y] 5,8,10; | [XY]GB2295966 (BIOGLAN IRELAND [IE]) [X] 1 * claims 1-30 * [Y] 5; | [YD]US5773647 (LEONE-BAY ANDREA [US], et al) [YD] 1-14 * column 47, line 47 - column 57, line 52; examples 1-8; claims 1-23 *; | [YD]US5866536 (LEONE-BAY ANDREA [US], et al) [YD] 1-14 * column 2, line 43 - column 24, line 54; figures 4,5,7; examples 5-15,34-43,50-58; claims 1-23 *; | [XY]US5972381 (SANGEKAR SURENDRA A [US], et al) [X] 1 * examples 6,12-20; claims 1,2 * [Y] 5; | [XY]WO0057857 (YUHAN CORP [KR]) [X] 1 * examples 1-13; claims 1-3 * [Y] 5; | [PA] - LEONE-BAY ANDREA ET AL, "Oral delivery of biologically active parathyroid hormone.", BIOSIS, BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US, (200107), Database accession no. PREV200100449260, XP002214663 [PA] 1-14 * abstract * | [ ] - PHARMACEUTICAL RESEARCH (NEW YORK), (200107), vol. 18, no. 7, ISSN 0724-8741, pages 964 - 970 | Examination | WO0059863 | WO0059480 |